Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |